|Daily Range||$1.20 - $1.28|
|52-Week Range||$1.07 - $2.94|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,592,053|
|Current FY EPS||-$0.44|
CTI BioPharma Corp. (CTIC) Description
CTI BioPharma Corp. Website: http://www.celltherapeutics.com/
Pricing details on a recently announced capital raise have investors selling off shares.
CTI BioPharma Initiates Rolling Submission of U.S. NDA for Pacritinib for Treatment of Patients with Myelofibrosis
With ongoing annual loss streaks of eight, 18, and 23 years, respectively, these companies might understandably seem hopeless.
With a heavy debt load, Incyte can't afford competition for Jakafi.